← Company intelligence

Robot maker · registered

Hangzhou RoboCT Technology Development Co.,Ltd

Corporate marketwearablesmedicalcareCurated record

RoboCT designs and builds AI-native lower-limb exoskeleton robots combining intelligent control systems, gait-adaptive algorithms and robotic core components (including its own motorized mecanum wheels and precision motion control). Products span clinical rehabilitation (UGO, KidGO, bedside/DEUS series) and consumer daily-mobility devices (EasyGo, GoGo) with adaptive walk/stand/cadence assist modes. It was the first Chinese firm to obtain NMPA registration for lower-limb exoskeleton robots treating central neuropathy, and holds FDA registration and CE certification for overseas markets.

HeadquartersHangzhou, CN
Founded2017
Corporate funding$15M
TeamNot listed
Deployments0
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A+ (RMB100M, 2022)
FoundersWang Tian (Founder & CEO)
Regions servedChina, United States, Europe, 30+ countries
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-16
MX

Robot models

Specifications remain vendor-claimed

Machineamr

DEUS

  • No specifications on file.
Machinewearables

EasyGo

  • 2.5kg, battery-free mechanical-support exoskeleton priced at RMB2,500; reduces user effort ~10%; sold out within 15 seconds at online launch

    Consumer-grade passive exoskeleton assistive device for stairs and long walks

    Claim source
Machinewearables

GoGo

  • 2.3kg per side (excluding battery); up to 25km range; adaptive Walk, Stand/Sit, Cadence Assist and Swing Assist modes

    Lightweight powered consumer exoskeleton for daily mobility, post-stroke and Parkinson's support, unveiled at CES 2026

    Claim source
Machinewearables

KidGO

  • Pediatric lower-limb rehabilitation exoskeleton for children

    Exoskeleton robot variant sized for pediatric gait rehabilitation

    Claim source
Machinewearables

UGO

  • Lower-limb rehabilitation exoskeleton deployed in 700+ hospitals; first in China with NMPA registration for central neuropathy (paraplegia, hemiplegia, cerebral palsy)

    Clinical rehab exoskeleton robot that retrains gait for spinal-cord-injury, stroke and lower-limb weakness patients

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordFortune CapitalBRV ChinaEssence SecuritiesPoly CapitalLanchi Venture CapitalAsia Business Capital
TL

Company timeline

Milestones and announcements

2026-01-05Unveils lightweight GoGo consumer exoskeleton series at CES 2026PR Newswire
2022-04-12Closes RMB100M Series A+ financing led by Fortune CapitalPR Newswire
SC

Source ledger

6 unique public sources